Monitor Dr. Reddy's response to the USFDA regarding the three Form 483 observations and any subsequent regulatory actions (e.g., warning letter, import alert) that could affect the Srikakulam facility's output or pending product approvals. The inspection was a PAI, so resolution is key for the associated product's launch timeline.
Price Chart
Executive Summary
Dr. Reddy's disclosed that the USFDA completed a 10-day Pre-Approval Inspection (PAI) and GMP inspection at its FTO-SEZ Process Unit-02 in Srikakulam, Andhra Pradesh, from July 20-29, 2026. The company received a Form 483 with three observations, which it will address within the stipulated timeline. This is a routine regulatory event with no material financial impact disclosed, but the three observations introduce minor regulatory risk for the facility's compliance status and potential product approvals tied to the PAI.
Key Facts
- USFDA completed a Pre-Approval Inspection (PAI) and GMP inspection at Dr. Reddy's FTO-SEZ Process Unit-02 in Srikakulam, Andhra Pradesh from July 20 to July 29, 2026.
- The company received a Form 483 with three observations, which it will address within the stipulated timeline.
- No financial figures, revenue impact, or material operational disruptions were disclosed in the filing.
Financial Impact
No financial impact disclosed; three Form 483 observations are routine and typically resolved without material cost.
Risk Factors
- Failure to adequately address the three Form 483 observations could lead to escalated FDA enforcement actions, including warning letters or import alerts.
- The PAI outcome may delay or block approval of the product(s) tied to the inspection, impacting future revenue expectations.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (RDY) — Batch item 1 | 0001575872-26-000538 |
| Document: 0001575872-26-000538-index.html | 0001575872-26-000538 |
| Document: 0001575872-26-000538.txt | 0001575872-26-000538 |
| 6-K Filing (RDY) — Batch item 4 | 0001575872-26-000538 |
| Document: 0001575872-26-000538-index.html | 0001575872-26-000538 |
| Document: 0001575872-26-000538.txt | 0001575872-26-000538 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $11.91 $11.55 | ▼ −3.02% | ▼ −2.56% | $12.25 (+2.85%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Aug 26, 2026 5w ago | 6-K | $12.22 $12.16 | ▼ −0.49% | ▼ −1.15% | $12.25 (+0.25%) |
Aug 17, 2026 6w ago | 6-K | $12.11 $12.15 | ▲ +0.33% | ▲ +1.01% | $12.25 (+1.16%) |
Aug 13, 2026 7w ago | 6-K | $12.42 $12.27 | ▼ −1.21% | ▼ −1.01% | $12.25 (−1.37%) |
Aug 10, 2026 7w ago | 6-K | $12.15 $12.45 | ▲ +2.47% | ▲ +2.79% | $12.25 (+0.82%) |
Aug 3, 2026 8w ago | 6-K | $12.07 $12.10 | ▲ +0.25% | ▼ −1.55% | $12.25 (+1.49%) |
Jul 29, 2026 9w ago | 6-K | $11.76 $11.83 | ▲ +0.60% | ▼ −1.08% | $12.25 (+4.17%) |
Jul 23, 2026 10w ago | 6-K | $11.80 $11.79 | ▼ −0.08% | ▼ −0.19% | $12.25 (+3.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access